SEC Info - Caladrius Biosciences, Inc. - ‘8-K’ for 7/10/20

SEC Info℠

Home

My Interests

Help

Please Sign In

Caladrius Biosciences, Inc. – ‘8-K’ for 7/10/20

On: Friday, 7/10/20, at 4:41pm ET · For: 7/10/20 · Accession #: 320017-20-60 · File #: 1-33650

Previous ‘8-K’: ‘8-K’ on / for 6/18/20 · Next: ‘8-K’ on / for 7/28/20 · Latest: ‘8-K’ on 4/17/24 for 4/15/24 · 14 References:

  As Of               Filer                 Filing    For·On·As Docs:Size

 7/10/20  Caladrius Biosciences, Inc.       8-K:1,3,9   7/10/20    4:481K

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     20K 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     75K 
 3: EX-10.1     Material Contract                                   HTML    158K 
 4: EX-10.2     Material Contract                                   HTML     93K

Filing Submission 0000320017-20-000060 – SGML Text

Original SGML Text submitted by:	Lisata Therapeutics, Inc. [ formerly Caladrius Biosciences, Inc. ]

To view the SGML, please refresh
this page.

↑Top

Caladrius Biosciences, Inc. – ‘8-K’ for 7/10/20

On: Friday, 7/10/20, at 4:41pm ET · For: 7/10/20 · Accession #: 320017-20-60 · File #: 1-33650

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

To view the SGML, please refresh
this page.